Definitive Radiation for High-Risk Spine Metastases

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorStony Brook University

About this trial

This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery

Eligibility criteria

Qualifiers

Any pathologically proven solid tumor diagnosis not of central nervous system origin with radiographic or pathologic evidence of metastatic disease

Metastatic spine involvement documented by imaging

Involvement of maximum 3 contiguous vertebral bodies at the index site

Intact neurologic function, or only minor neurologic deficits with muscle strength greater or equal to 4 out of 5 with or without steroids

Disqualifiers

None

Trial design

Treatments tested in this trial

  • SBRT to the spine

Treatment groups

26 Participants
are divided into 1 treatment group

Sponsors and collaborators

Stony Brook University

Lead sponsor

The University of Texas Health Science Center at San Antonio

Collaborator